Novel Hybrid Molecules for Anticancer Therapy: A Comprehensive Review

Clicks: 8
ID: 309251
2024
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #23 of 153 articles by views in International Journal of Pharmaceutical Drug Design (IJPDD)

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 153 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The investigation of novel hybrid molecules has been prompted by the search for effective anticancer medicines. These molecules offer intriguing pathways for battling cancer through creative processes, and they have been the subject of this investigation. This extensive study provides a synthesis of the existing literature on hybrid compounds that have been created for anticancer therapy. It sheds light on the various structural compositions of these molecules as well as the many mechanisms of action that they possess. The review begins with an overview of traditional anticancer techniques and the limits of those approaches. It then goes on to outline the logic for harnessing hybrid molecules, highlighting the potential of hybrid molecules to overcome resistance and boost therapeutic efficacy. The advantages of hybrid molecules over conventional medicines are highlighted, along with the many methodologies for building hybrid molecules, such as conjugation, combination, and hybridization of pharmacophores. In addition, molecular targets that are essential for the progression of cancer and treatment are investigated, which offers insights into the rational design of hybrid compounds. In this study, the significance of hybrid molecules in preclinical and clinical settings is highlighted by the presentation of sample case studies. These case studies provide light on the chemical structures, mechanisms of action, and therapeutic results of hybrid molecules. Techniques for synthesis and characterisation are investigated, with a particular focus on the significance of structure-activity relationship studies in the process of developing hybrid compounds for inhibitory efficacy against cancer. Additionally, the obstacles that are currently being faced in the field as well as the future approaches that are being pursued are discussed, which paves the way for further developments in the creation and translation of novel hybrid molecules for the treatment of cancer.
Reference Key
imported_1761930136_6904eb98f3677 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Muskan Bhardwaj
Journal International Journal of Pharmaceutical Drug Design (IJPDD)
Year 2024
DOI
10.62896/ijpdd.1.6.12
URL
https://ijpdd.org/index.php/files/article/view/139
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.